|
| 1 |
Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase–Low Squamous Cell Lung Cancer
Mihong Choi, Heung Tae Kim, Ji-Youn Han, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Hye Jin Won, Jin Soo Lee, Youngjoo Lee
Cancer Res Treat.2021;53(1):87-92. Published online 2020 August 13
DOI: http://dx.doi.org/10.4143/crt.2020.741
|
|
| 2 |
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, Yoon Hee Choi, Hye Ryun Kim, Hoon-Gu Kim, Heui June Ahn, Ha Yeon Lee, Hwan Jung Yun, Jin-Hyoung Kang, Jaeheon Jeong, Moon Young Choi, Sin-Ho Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.2019;51(2):718-726. Published online 2018 September 3
DOI: http://dx.doi.org/10.4143/crt.2018.324
|
|
| 3 |
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
Seung Sook Paik, In Kyoung Hwang, Myung Jae Park, Seung Hyeun Lee
|
|
| 4 |
Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
Jaemin Jo, Se Hyun Kim, Yu Jung Kim, Juhyun Lee, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jin-Haeng Chung, Yoon Kyung Jeon, Jong Seok Lee
Yonsei Med J.2018;59(2):202-210. Published online 2018 February 5
DOI: http://dx.doi.org/10.3349/ymj.2018.59.2.202
|
|
| 5 |
A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin
Jung Sun Kim, Sang Yup Lim, Jinwook Hwang, Eun Joo Kang, Yoon Ji Choi
|
|
| 6 |
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
Makoto Nishio, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Benjamin J. Solomon, Alice T. Shaw, Satoshi Hashigaki, Emiko Ohki, Tiziana Usari, Jolanda Paolini, Anna Polli, Keith D. Wilner, Tony Mok
|
|
| 7 |
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
Jin Hyoung Kang, Myung-Ju Ahn, Dong-Wan Kim, Eun Kyung Cho, Joo-Hang Kim, Sang Won Shin, Xin Wang, Jong Seok Kim, Mauro Orlando, Keunchil Park
Cancer Res Treat.2016;48(2):458-464. Published online 2015 October 14
DOI: http://dx.doi.org/10.4143/crt.2015.135
|
|
| 8 |
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
Young Saing Kim, Eun Kyung Cho, Hyun Sun Woo, Junshik Hong, Hee Kyung Ahn, Inkeun Park, Sun Jin Sym, Sun Young Kyung, Shin Myung Kang, Jeong-Woong Park, Sung Hwan Jeong, Jinny Park, Jae Hoon Lee, Dong Bok Shin
|
|
| 9 |
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
Sehhoon Park, Bhumsuk Keam, Se Hyun Kim, Ki Hwan Kim, Yu Jung Kim, Jin-Soo Kim, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo
Cancer Res Treat.2015;47(4):630-637. Published online 2015 February 16
DOI: http://dx.doi.org/10.4143/crt.2014.244
|
|
| 10 |
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Dae Ho Lee, Jung Shin Lee, Jie Wang, Te-Chun Hsia, Xin Wang, Jongseok Kim, Mauro Orlando
Cancer Res Treat.2015;47(4):616-629. Published online 2014 November 24
DOI: http://dx.doi.org/10.4143/crt.2014.051
|
|
| 11 |
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT
James Chin-Hsin Yang, Myung-Ju Ahn, Kazuhiko Nakagawa, Tomohide Tamura, Helen Barraclough, Sotaro Enatsu, Rebecca Cheng, Mauro Orlando
Cancer Res Treat.2015;47(3):424-435. Published online 2014 September 15
DOI: http://dx.doi.org/10.4143/crt.2013.266
|
|
| 12 |
Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib
Hyojeong Kim, Tak Yun, Young Joo Lee, Ji-Youn Han, Heung Tae Kim, Geon Kook Lee
|
|
| 13 |
Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
Minkyu Jung, Chul Ho Lee, Hyung Soon Park, Ji Hyun Lee, Young Ae Kang, Se Kyu Kim, Joon Chang, Dae Joon Kim, Sun Young Rha, Joo Hang Kim, Byoung Chul Cho
|
|
| 14 |
Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
Kyeong-Hyun Kim, Seo-Young Song, Kyu-Hyoung Lim, Seon-Sook Han, Se-Hyun Kim, Jun Hwi Cho, Chan Woo Park, Seoungkoo Lee, Hui-Young Lee
|
|
| 15 |
Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase Expression
Choel-Kyu Park, Kyu-Sik Kim, In-Jae Oh, Manaljav Tseden-Ish, Yoo-Duk Choi, Yong-Soo Kwon, Yoo-Il Kim, Sung-Chul Lim, Young-Chul Kim
|
|
| 16 |
Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma
Gyu Jin Lee, Mann Hong Jung, Tae Won Jang, Chul Ho Ok, Hyun Joo Jung
|
|
| 17 |
Dramatic Tumor Response to 2nd-line Pemetrexed/Cisplatin Combination Chemotherapy in Patient with Malignant Pleural Mesothelioma
Seung Min Lee, Soon Young Ko, Tae Ho Seo, Jung Hyun Lee, Seung Oh Choi, Jeong Geun Lee, Wan Seop Kim, Tae Hoon Lee, Gwang Ha Yoo, Kye Young Lee
|
|
